Search research articles
Contact Us
Filters
Showing results (71-80 of 100) with videos related to
Page
of 10
Sort By:
JCO Precision Oncology
|
April 10, 2025
Clinicomolecular Profile and Efficacy of Human Epidermal Growth Factor Receptor 2 (HER2)-Targeted Therapy for <i>HER2</i>-Amplified Advanced Biliary Tract Cancer
Kanae Inoue, Yoshiaki Nakamura, Bennett Caughey, et al.
The Oncologist
|
July 21, 2021
First-In-Human, First-In-Class, Phase I Trial of the Fucosylation Inhibitor SGN-2FF in Patients with Advanced Solid Tumors
Khanh T Do, Laura Quan Man Chow, Karen Reckamp, et al.
Cancer Chemotherapy and Pharmacology
|
August 25, 2019
A phase Ib study of the combination regorafenib with PF-03446962 in patients with refractory metastatic colorectal cancer (REGAL-1 trial)
Jeffrey Melson Clarke, Gerard C Blobe, John H Strickler, et al.
Annals of Surgery
|
November 8, 2022
Hepatic Artery Infusion Pumps: A Surgical Toolkit for Intraoperative Decision-Making and Management of Hepatic Artery Infusion-Specific Complications
Jeremy M Sharib, John M Creasy, Benjamin Wildman-Tobriner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2016
Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Edward P Balaban, Pamela B Mangu, Alok A Khorana, et al.
Journal of Gastrointestinal Oncology
|
November 16, 2023
Identification of an optimal mutant allele frequency to detect activating <i>KRAS</i>, <i>NRAS</i>, and <i>BRAF</i> mutations in a commercial cell-free DNA next-generation sequencing assay in colorectal and pancreatic adenocarcinomas
Bennett A Caughey, Kumiko Umemoto, Michelle F Green, et al.
Investigational New Drugs
|
November 1, 2013
Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer
John H Strickler, Shannon McCall, Andrew B Nixon, et al.
Annals of Surgical Oncology
|
November 20, 2024
Perioperative and Oncologic Outcomes of Hepatic Arterial Infusion (HAI) Pump Chemotherapy for Patients with Unresectable Colorectal Liver Metastases at an Expanding HAI Program
Annie Liu, Melissa Lowe, Donna Niedzwiecki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 30, 2026
Telisotuzumab Adizutecan (ABBV-400), a Novel c-Met-Targeting Antibody-Drug Conjugate: First-in-Human Results in Advanced Gastric/Gastroesophageal Junction Cancer
John H Strickler, Judith Raimbourg, Jonathan E Cohen, et al.
Cancer Discovery
|
December 3, 2017
Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer
John H Strickler, Jonathan M Loree, Leanne G Ahronian, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 100) with videos related to
Sort By:
Page
of 10
JCO Precision Oncology
|
April 10, 2025
Clinicomolecular Profile and Efficacy of Human Epidermal Growth Factor Receptor 2 (HER2)-Targeted Therapy for <i>HER2</i>-Amplified Advanced Biliary Tract Cancer
Kanae Inoue, Yoshiaki Nakamura, Bennett Caughey, et al.
The Oncologist
|
July 21, 2021
First-In-Human, First-In-Class, Phase I Trial of the Fucosylation Inhibitor SGN-2FF in Patients with Advanced Solid Tumors
Khanh T Do, Laura Quan Man Chow, Karen Reckamp, et al.
Cancer Chemotherapy and Pharmacology
|
August 25, 2019
A phase Ib study of the combination regorafenib with PF-03446962 in patients with refractory metastatic colorectal cancer (REGAL-1 trial)
Jeffrey Melson Clarke, Gerard C Blobe, John H Strickler, et al.
Annals of Surgery
|
November 8, 2022
Hepatic Artery Infusion Pumps: A Surgical Toolkit for Intraoperative Decision-Making and Management of Hepatic Artery Infusion-Specific Complications
Jeremy M Sharib, John M Creasy, Benjamin Wildman-Tobriner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2016
Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Edward P Balaban, Pamela B Mangu, Alok A Khorana, et al.
Journal of Gastrointestinal Oncology
|
November 16, 2023
Identification of an optimal mutant allele frequency to detect activating <i>KRAS</i>, <i>NRAS</i>, and <i>BRAF</i> mutations in a commercial cell-free DNA next-generation sequencing assay in colorectal and pancreatic adenocarcinomas
Bennett A Caughey, Kumiko Umemoto, Michelle F Green, et al.
Investigational New Drugs
|
November 1, 2013
Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer
John H Strickler, Shannon McCall, Andrew B Nixon, et al.
Annals of Surgical Oncology
|
November 20, 2024
Perioperative and Oncologic Outcomes of Hepatic Arterial Infusion (HAI) Pump Chemotherapy for Patients with Unresectable Colorectal Liver Metastases at an Expanding HAI Program
Annie Liu, Melissa Lowe, Donna Niedzwiecki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 30, 2026
Telisotuzumab Adizutecan (ABBV-400), a Novel c-Met-Targeting Antibody-Drug Conjugate: First-in-Human Results in Advanced Gastric/Gastroesophageal Junction Cancer
John H Strickler, Judith Raimbourg, Jonathan E Cohen, et al.
Cancer Discovery
|
December 3, 2017
Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer
John H Strickler, Jonathan M Loree, Leanne G Ahronian, et al.
Page
of 10